Enhanced Topoisomerase I Activity and Increased Topoisomerase IIα Content in Cisplatin-resistant Cancer Cell Lines

This publication has 29 references indexed in Scilit:

• Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancer
  American Journal of Obstetrics and Gynecology, 1996
• Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells
  Japanese Journal of Cancer Research, 1994
• Effect of novobiocin on cisplatin cytotoxicity and dna interstrand cross‐link formation in a cisplatin‐resistant, small‐cell lung carcinoma cell line
  International Journal of Cancer, 1993
• Effects of CPT‐11 in combination with other anti‐cancer agents in culture
  International Journal of Cancer, 1992
• Salvage chemotherapy for ovarian cancer recurrence: Weekly cisplatin in combination with epirubicin or etoposide
  Gynecologic Oncology, 1991
• Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell Line
  Japanese Journal of Cancer Research, 1990
• Mitoxantrone affects topoisomerase activities in human breast cancer cells
  Biochemical and Biophysical Research Communications, 1986
• A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
  Analytical Biochemistry, 1976
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970